McKesson Return on Investment 2010-2022 | MCK

Current and historical return on investment (ROI) values for McKesson (MCK) over the last 10 years.
McKesson ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-06-30 $2.51B $10.64B 21.78%
2022-03-31 $2.04B $10.51B 16.51%
2021-12-31 $2.42B $11.88B 18.05%
2021-09-30 $-5.25B $13.01B -37.54%
2021-06-30 $-5.15B $13.98B -37.58%
2021-03-31 $-5.04B $14.65B -38.12%
2020-12-31 $-5.18B $14.26B -41.54%
2020-09-30 $2.54B $11.94B 20.85%
2020-06-30 $2.53B $12.05B 19.93%
2020-03-31 $2.49B $11.64B 18.35%
2019-12-31 $1.05B $13.12B 7.23%
2019-09-30 $1.37B $14.03B 8.86%
2019-06-30 $1.44B $15.45B 8.97%
2019-03-31 $0.89B $15.55B 5.46%
2018-12-31 $0.51B $17.01B 3.09%
2018-09-30 $0.66B $16.10B 3.86%
2018-06-30 $0.21B $16.24B 1.19%
2018-03-31 $0.76B $16.81B 4.11%
2017-12-31 $6.45B $19.49B 33.99%
2017-09-30 $6.44B $18.85B 36.71%
2017-06-30 $6.78B $18.94B 40.56%
2017-03-31 $7.12B $18.58B 44.94%
2016-12-31 $3.12B $13.82B 20.71%
2016-09-30 $3.21B $15.56B 20.34%
2016-06-30 $3.59B $15.43B 22.20%
2016-03-31 $3.55B $15.51B 21.40%
2015-12-31 $3.51B $16.68B 20.92%
2015-09-30 $3.39B $17.01B 19.77%
2015-06-30 $3.22B $17.08B 17.97%
2015-03-31 $2.97B $16.27B 15.73%
2014-12-31 $2.87B $18.14B 14.65%
2014-09-30 $2.57B $20.15B 14.09%
2014-06-30 $2.47B $20.91B 15.12%
2014-03-31 $2.44B $19.25B 17.35%
2013-12-31 $2.50B $12.55B 20.59%
2013-09-30 $2.51B $12.51B 21.04%
2013-06-30 $2.43B $11.93B 21.13%
2013-03-31 $2.35B $11.59B 21.20%
2012-12-31 $2.36B $11.62B 22.18%
2012-09-30 $2.36B $10.79B 22.44%
2012-06-30 $2.23B $10.28B 21.27%
2012-03-31 $2.12B $9.90B 20.17%
2011-12-31 $2.07B $11.03B 19.20%
2011-09-30 $1.88B $10.69B 18.17%
2011-06-30 $1.82B $10.49B 18.29%
2011-03-31 $1.82B $10.81B 18.95%
2010-12-31 $1.77B $9.39B 18.91%
2010-09-30 $1.97B $9.09B 21.05%
2010-06-30 $2.02B $9.16B 21.63%
2010-03-31 $2.01B $9.83B 21.82%
2009-12-31 $1.93B $9.42B 21.80%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $53.389B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $76.093B 22.10
AmerisourceBergen (ABC) United States $31.591B 13.95
West Pharmaceutical Services (WST) United States $25.237B 38.42
Laboratory Of America Holdings (LH) United States $24.116B 10.55
Cardinal Health (CAH) United States $19.062B 13.83
Cooper (COO) United States $16.446B 25.31
CONMED (CNMD) United States $3.144B 30.99
Invacare (IVC) United States $0.035B 0.00